Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-06-17

Clinical Trial Update: Effect of Benoxinate Hydrochloride Eye Drops on The Premature Infant Pain Profile Score During Retinopathy of Prematurity Screening [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating whether Benoxinate Hydrochloride Eye Drops reduce Premature Infant Pain Profile scores during retinopathy of prematurity scree…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Benoxinate Hydrochloride Eye Drops (benoxinate hydrochloride)

Snippet

Sponsor: Alexandria University | Conditions: Retinopathy of Prematurity | Phase 3 | Status: COMPLETED